Large granular lymphocytic leukemia: molecular pathogenesis, clinical manifestations, and treatment.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2012, Issue , 2012, Pages 652-659

  Zhang, Dan ^a   Loughran, Thomas P ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CYCLOPHOSPHAMIDE; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; STAT3 PROTEIN;

AGED; ALGORITHM; BIOLOGICAL MODEL; BIOSYNTHESIS; CLINICAL TRIAL (TOPIC); CYTOLOGY; HUMAN; IMMUNOLOGY; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; LEUKEMIA; METABOLISM; MIDDLE AGED; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TREATMENT OUTCOME;

AGED; ALGORITHMS; ANTIGENS, CD3; ANTIGENS, CD95; CLINICAL TRIALS AS TOPIC; CYCLOPHOSPHAMIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; METHOTREXATE; MIDDLE AGED; MODELS, BIOLOGICAL; NF-KAPPA B; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84877297522     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation.v2012.1.652.3798658     Document Type: Review

References (0)